Yeastbiotic is SCD Compliant that can be used to treat diarrhea or other antibiotic-related problems stemming from systemic yeast overgrowth.
Yeastbiotic contains Saccharomyces boulardii, a non-pathogenic, transient yeast long-used for diarrhea or dysentery. It also contains small amounts of NON-GMO hydroxypropyl methylcellulose (from pine bark) water and L-leucine (an amino acid).
It augments colon bifidobacteria populations and increases butyrate concentrations. It also enhances brush border enzyme activities and improves gut barrier function. Yeastbiotic is ideal for broad antimicrobial activities against C. dificile, toxigenic E. coli, Candida, and other gastrointestinal pathogens.
Yeastbiotic is naturally resistant to all antibacterial antibiotics and can be taken along with antibacterial antibiotics without adversely affecting its potency and efficacy.
S. boulardii is genetically and functionally distinct from brewer’s yeast (S. cerevisiae) and different from pathogenic Candida species.
Research has found that S. boulardii supports healthy intestinal function in an array of clinical settings including antibiotic-associated diarrhea, C. difficile disease, inflammatory bowel disease, irritable bowel syndrome, and traveler’s diarrhea.